The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...

A bipartisan, bicameral group of lawmakers is calling on the Federal Trade Commission (FTC) to vote in favor of releasing an ...

The U.S. district judge in Cleveland, Ohio handling a galaxy of claims stemming from the prescription opioid epidemic on ...

The report also named about three dozen online retailers, many of them in China or elsewhere in Asia that it said are ...

Kentucky will receive $110 million to settle its lawsuit accusing one of the nation’s largest grocery chains of helping fuel ...

AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...